Pharmacokinetics (PK)

Definition

Pharmacokinetics is the branch of pharmacology that describes what the body does to a compound—specifically, how the drug or peptide is absorbed from the site of administration, distributed throughout the body, metabolized (chemically modified), and excreted. Pharmacokinetic studies measure plasma (or tissue) concentrations of the compound over time following administration, typically producing a concentration-versus-time curve. From these data, pharmacokinetic parameters are calculated, including peak concentration (Cmax), time to peak concentration (Tmax), area under the curve (AUC), half-life, clearance, and volume of distribution. Understanding the pharmacokinetics of a peptide compound is essential for establishing appropriate doses, dosing intervals, and routes of administration. Pharmacokinetic data is required by regulatory agencies such as the TGA to evaluate whether a new therapeutic peptide is suitable for the proposed use. Preclinical pharmacokinetic studies in animal models inform the design of early clinical pharmacokinetic studies in humans.

The pharmacokinetic profile of a compound influences its clinical utility and research applicability. A peptide with rapid absorption, high bioavailability, and longer half-life is more convenient to administer and may produce more stable plasma concentrations than a peptide with slow absorption and rapid elimination. Some peptides show linear kinetics (proportional increase in plasma concentration with increasing dose), while others show nonlinear kinetics (due to saturation of absorption, metabolism, or elimination processes). Understanding whether kinetics are linear or nonlinear is important for dose scaling and for predicting how plasma concentrations will change when dosage is adjusted.

Pharmacokinetic variability—differences between individuals in absorption, metabolism, or clearance—affects how different people respond to the same dose. Sources of variability include genetic differences in metabolizing enzymes, liver and kidney function, body weight and composition, age, sex, and concomitant medications or foods. Pharmacogenomic studies investigate how genetic variation affects pharmacokinetics and response. In research contexts, characterizing the pharmacokinetic properties of investigational peptides helps explain mechanisms of action and helps predict which patients might benefit or experience toxicity.